PULSE BIOSCIENCES, INC. (PLSE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 500K 1M 1.5M Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 86K Q4 '25: 350K Q1 '26: 751K Q2 '26: 1.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q2 '23: -9.7M Q3 '23: -1.3M Q4 '23: 0 Q2 '25: 0 Q3 '25: -193K Q4 '25: -189K Q1 '26: -158K Q2 '26: 3K Q2 '23 Q3 '23 Q4 '23 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '24: -48.5M Q4 '24: -56.3M Q1 '25: -63.7M Q2 '25: -72.2M Q3 '25: -78.9M Q4 '25: -76.9M Q1 '26: -78M Q2 '26: -83M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '24: -46.1M Q4 '24: -53.6M Q1 '25: -60.2M Q2 '25: -68M Q3 '25: -74.7M Q4 '25: -72.8M Q1 '26: -74.6M Q2 '26: -80.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 3.5M 7M 10.5M Q2 '23: 9.7M Q3 '23: 1.3M Q4 '23: 0 Q2 '25: 0 Q3 '25: 279K Q4 '25: 539K Q1 '26: 909K Q2 '26: 1.2M Q2 '23 Q3 '23 Q4 '23 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q3 '24: -34M Q4 '24: -36.3M Q1 '25: -40.1M Q2 '25: -44.5M Q3 '25: -48.5M Q4 '25: -54.1M Q1 '26: -55.2M Q2 '26: -61.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q3 '24: -34.1M Q4 '24: -36.5M Q1 '25: -40.2M Q2 '25: -44.7M Q3 '25: -48.8M Q4 '25: -54.4M Q1 '26: -55.5M Q2 '26: -61.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q1 '24: 57.1M Q2 '24: 57.2M Q3 '24: 61.1M Q1 '25: 67.1M Q2 '25: 67.3M Q3 '25: 67.4M Q1 '26: 68M Q2 '26: 69.2M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q3 '24: -0.80 Q4 '24: -0.91 Q1 '25: -0.98 Q2 '25: -1.06 Q3 '25: -1.14 Q4 '25: -1.08 Q1 '26: -1.10 Q2 '26: -1.18 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.